−500 KRW
−12.73 B KRW
31.72 B KRW
21.49 M
About MEZZION PHARMA CO., LTD.
Sector
CEO
Dong-Hyun Park
Headquarters
Seoul
Website
Founded
2002
ISIN
KR7140410002
FIGI
BBG0029RPD64
Mezzion Pharma Co., Ltd. engages in the development, production, and licensing of pharmaceutical products. Its products include erectile dysfunction, benign prostatic hyperplasia, and fontan therapeutic drugs. The company was founded by Park, Dong-Hyun on September 25, 2002 and is headquartered in Seoul, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 140410 is 30,850 KRW — it has decreased by −3.14% in the past 24 hours. Watch MEZZION PHARMA CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange MEZZION PHARMA CO., LTD. stocks are traded under the ticker 140410.
140410 stock has fallen by −5.23% compared to the previous week, the month change is a −0.48% fall, over the last year MEZZION PHARMA CO., LTD. has showed a −17.07% decrease.
140410 reached its all-time high on Nov 12, 2019 with the price of 85,850 KRW, and its all-time low was 4,550 KRW and was reached on Dec 13, 2013. View more price dynamics on 140410 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
140410 stock is 2.95% volatile and has beta coefficient of 0.56. Track MEZZION PHARMA CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is MEZZION PHARMA CO., LTD. there?
Today MEZZION PHARMA CO., LTD. has the market capitalization of 922.87 B, it has decreased by −7.69% over the last week.
Yes, you can track MEZZION PHARMA CO., LTD. financials in yearly and quarterly reports right on TradingView.
140410 net income for the last quarter is −6.33 B KRW, while the quarter before that showed −1.62 B KRW of net income which accounts for −291.37% change. Track more MEZZION PHARMA CO., LTD. financial stats to get the full picture.
No, 140410 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 21.00 employees. See our rating of the largest employees — is MEZZION PHARMA CO., LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEZZION PHARMA CO., LTD. EBITDA is −12.47 B KRW, and current EBITDA margin is −40.80%. See more stats in MEZZION PHARMA CO., LTD. financial statements.
Like other stocks, 140410 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEZZION PHARMA CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEZZION PHARMA CO., LTD. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEZZION PHARMA CO., LTD. stock shows the sell signal. See more of MEZZION PHARMA CO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.